Checkpoint Therapeutics, Inc.
(NASDAQ : CKPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.04%172.250.7%$1088.53m
PFEPfizer Inc. -0.02%42.780.9%$1062.98m
AZNAstraZeneca Plc -0.69%57.241.0%$983.21m
MRKMerck & Co., Inc. -0.13%76.830.7%$651.89m
ABBVAbbVie, Inc. -2.22%116.231.9%$651.72m
BMYBristol-Myers Squibb Co. -0.34%67.921.0%$580.36m
LLYEli Lilly & Co. -0.80%243.361.1%$577.91m
NRXPNRX Pharmaceuticals, Inc. 0.20%15.180.0%$167.78m
NVSNovartis AG 0.25%92.420.2%$154.78m
GSKGlaxoSmithKline Plc 0.13%40.150.2%$154.55m
RGENRepligen Corp. 1.95%245.706.8%$95.53m
VTRSViatris, Inc. -1.54%14.070.0%$86.29m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.06%126.060.0%$85.37m
NVONovo Nordisk A/S 1.32%92.580.1%$81.36m
RPRXRoyalty Pharma Plc -0.13%38.200.2%$73.90m

Company Profile

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in New York, NY.